Fact-checked by Grok 2 weeks ago

Vasodilation

Vasodilation is the widening of blood vessels, resulting from the relaxation of the smooth muscle cells in their walls, which decreases vascular resistance and increases blood flow to specific tissues or organs.^[1] This physiological process is essential for maintaining adequate perfusion in response to metabolic demands, such as during exercise or digestion, and for regulating systemic blood pressure by reducing systemic vascular resistance.^[1] Vasodilation contrasts with vasoconstriction, the narrowing of vessels, and together they dynamically control circulation throughout the body.^[2] The mechanisms of vasodilation are broadly classified into endothelium-dependent and endothelium-independent pathways. In endothelium-dependent vasodilation, stimuli such as shear stress from blood flow, acetylcholine, bradykinin, histamine, ATP, or adenosine activate endothelial cells to produce relaxing factors, primarily nitric oxide (NO) via endothelial nitric oxide synthase (eNOS) and prostacyclin via cyclooxygenase (COX) pathways.^[1] These factors diffuse to the adjacent vascular smooth muscle cells, where NO stimulates guanylate cyclase to increase cyclic guanosine monophosphate (cGMP), and prostacyclin elevates cyclic adenosine monophosphate (cAMP), both leading to decreased intracellular calcium levels and muscle relaxation.^[1] Endothelium-independent vasodilation occurs directly on smooth muscle cells, often through agents like nitrates or calcium channel blockers that mimic or bypass endothelial signals to achieve similar relaxation effects.^[1] Physiologically, vasodilation plays a critical role in adapting blood flow to tissue needs, such as enhancing delivery of oxygen and nutrients during increased metabolic activity in skeletal muscles or the brain.^[1] It also contributes to thermoregulation by dilating cutaneous vessels to dissipate heat and to the inflammatory response by increasing permeability and leukocyte recruitment at injury sites.^[2] In the cardiovascular system, coordinated vasodilation helps lower blood pressure and prevent hypertension, while in the kidneys, it supports glomerular filtration rate regulation.^[3] In health, balanced vasodilation ensures optimal organ function, but dysregulation is implicated in various diseases; for instance, impaired endothelial-dependent vasodilation contributes to atherosclerosis, hypertension, and erectile dysfunction due to reduced NO bioavailability from oxidative stress or endothelial damage.^[4] Conversely, excessive vasodilation can lead to hypotension in conditions like sepsis or anaphylaxis, highlighting the therapeutic potential of modulating these pathways with drugs such as phosphodiesterase inhibitors or NO donors.^[1]

Introduction

Definition

Vasodilation refers to the widening or dilation of blood vessels, which occurs primarily through the relaxation of smooth muscle cells in the tunica media, the middle layer of the vessel wall, thereby increasing the vessel diameter and the size of the lumen.^[1] This process contrasts with vasoconstriction, where smooth muscle contraction narrows the vessel lumen, and with passive distension due to elevated intraluminal pressure, as vasodilation involves active physiological modulation.^[5] Vasodilation takes place across various vessel types, including arteries, arterioles, veins, and venules, though it is most pronounced in resistance vessels such as arterioles, where changes in diameter exert the greatest influence on overall blood flow dynamics.^[6] In these small vessels, stimuli can typically induce a 20-50% increase in diameter, dramatically reducing vascular resistance in accordance with Poiseuille's law, expressed as R \propto \frac{1}{r^4}, where R is resistance and r is the vessel radius; even modest radius increases yield disproportionately large drops in resistance due to the fourth-power relationship.^[5] The term "vasodilation" was coined in the late 19th century amid physiologists' investigations into circulatory control, emerging around 1896 from the prefix "vaso-" combined with "dilation." Early experimental insights into active dilation were provided by William Bayliss in 1902, who observed vascular responses to pressure changes in isolated preparations, laying groundwork for understanding intrinsic vessel reactivity beyond neural influences.^[7]

Physiological Significance

Vasodilation is essential for maintaining systemic homeostasis by facilitating the dynamic redistribution of blood flow to tissues with heightened metabolic demands, thereby preventing ischemia and ensuring efficient delivery of oxygen and nutrients. This process allows the circulatory system to respond to local signals, such as reduced oxygen levels or increased metabolic byproducts, enhancing perfusion in active or hypoxic regions while conserving resources elsewhere.^[1]^[8] By decreasing total peripheral resistance (TPR), vasodilation reduces the afterload imposed on the heart, thereby alleviating cardiac workload and preventing excessive strain during periods of increased demand. This relationship is captured in the equation for mean arterial pressure:

\text{MAP} = \text{CO} \times \text{TPR}

where a reduction in TPR lowers the pressure the heart must generate to maintain adequate perfusion, supporting overall cardiovascular efficiency.^[9]^[5] From an evolutionary standpoint, vasodilation is a highly conserved mechanism across vertebrates, enabling adaptation to diverse environmental challenges like hypoxia or thermal stress, as demonstrated by comparative physiology studies revealing similar nitric oxide-mediated vasomotor responses from fish to mammals.^[10]^[11] In clinical practice, the physiological significance of vasodilation is evaluated through non-invasive methods, including Doppler ultrasound to measure flow-mediated dilation in conduit arteries and venous occlusion plethysmography to quantify changes in limb blood flow, providing insights into vascular health without invasive procedures.^[12]^[13] Vasodilation contrasts with vasoconstriction, its physiological antagonist, to enable precise regulation of vascular tone.

Physiological Functions

Blood Flow Regulation

Vasodilation plays a central role in local autoregulation of blood flow, particularly in metabolically active tissues where it matches oxygen delivery to demand. In response to increased metabolic activity, factors such as adenosine, elevated carbon dioxide (CO2), and reduced oxygen (O2) levels trigger vasodilation of arterioles, enhancing capillary perfusion by up to 10-fold to support tissue oxygenation and nutrient supply.^[14]^[15] This metabolic vasodilation is mediated primarily through the relaxation of vascular smooth muscle in response to these local signals, ensuring efficient blood flow redistribution without relying on central neural control.^[16] Organ-specific adaptations highlight vasodilation's precision in blood flow regulation. In the coronary circulation, exercise induces vasodilation via increased shear stress on endothelial cells, which promotes the release of relaxing factors to elevate myocardial blood flow and meet heightened cardiac demands.^[17] Similarly, cerebral autoregulation maintains constant blood flow across a wide range of mean arterial pressures (60-160 mmHg) through myogenic and metabolic vasodilation of cerebral arterioles, preventing ischemia or hyperperfusion during fluctuations in systemic pressure.^[18] Endothelial-derived factors like nitric oxide briefly enable these responses by facilitating signal transduction in the vessel wall.^[17] Systemically, vasodilation contributes to baroreceptor-mediated control of hypotension by modulating vascular resistance in response to pressure changes. Activation of arterial baroreceptors during elevated blood pressure inhibits sympathetic vasoconstriction, promoting dilation in large arteries to reduce systolic pressure and restore homeostasis.^[19] A striking example of this regulatory impact occurs in skeletal muscle, where vasodilation can increase blood flow from approximately 5 mL/min/100g at rest to 50-100 mL/min/100g during intense activity, optimizing perfusion for contraction and recovery.^[14]

Thermoregulation

Vasodilation serves as a primary mechanism for thermoregulation by promoting heat dissipation through the skin, particularly via the dilation of cutaneous arteriovenous anastomoses (AVAs) and capillaries. These specialized structures, abundant in areas like the hands, feet, and face, allow for rapid increases in blood flow to the skin surface when core body temperature rises. This elevated perfusion enhances radiative heat loss—where the skin emits infrared radiation to cooler surroundings—and convective heat loss, as warmed blood transfers heat to the air or contacting surfaces. By redirecting blood to the periphery, vasodilation minimizes heat retention in the body's core, preventing hyperthermia during environmental heat exposure or exercise.^[20]^[21] The neural control of this process originates in the hypothalamus, which acts as the central thermostat integrating inputs from thermoreceptors throughout the body. When core temperature surpasses approximately 37°C, the preoptic area of the hypothalamus activates sympathetic cholinergic efferent pathways to cutaneous vessels, triggering active vasodilation. This cholinergic mechanism is distinct from the default noradrenergic sympathetic tone that maintains baseline vasoconstriction; instead, it involves the release of acetylcholine from nerve endings, which promotes relaxation of vascular smooth muscle either directly or via secondary messengers. This reflex ensures a proportional response to thermal load, with vasodilation onset and magnitude scaling with the degree of hyperthermia.^[22]^[23]^[24] In humans, the thermoregulatory impact of cutaneous vasodilation is profound under heat stress conditions. At rest in thermoneutral environments, skin blood flow typically accounts for 5-10% of cardiac output, supporting minimal heat exchange. During intense heat exposure, however, this can surge to 50-70% of cardiac output, channeling up to 7 liters per minute of blood to the skin and enabling heat dissipation rates sufficient to lower or stabilize core temperature by 1-2°C against ongoing metabolic or environmental heat loads. This redistribution, while effective for cooling, imposes cardiovascular demands by requiring elevated cardiac output to sustain both peripheral and visceral perfusion.^[25]^[26]^[27] Impairments in thermoregulatory vasodilation can compromise heat loss, as seen in Raynaud's phenomenon—a disorder primarily defined by episodic, exaggerated vasoconstriction in response to cold or stress. Although vasoconstrictive in nature, Raynaud's also disrupts the dilatory response to warmth, resulting in blunted increases in skin blood flow during heat stress and heightened vulnerability to overheating or thermal inefficiency. This dysfunction arises from endothelial abnormalities and altered sympathetic signaling, underscoring vasodilation's critical role in adaptive thermoregulation.^[28]^[29]

Immune and Inflammatory Roles

Vasodilation plays a central role in the acute inflammatory response by facilitating the recruitment of immune cells to sites of injury or infection. Upon activation by allergens, pathogens, or tissue damage, mast cells rapidly release pre-formed mediators such as histamine, which binds to H1 receptors on endothelial cells, inducing arteriolar dilation and increasing vascular permeability. This dilation enhances blood flow to the affected area, while the accompanying permeability allows plasma proteins and leukocytes to extravasate into the tissue, initiating the inflammatory cascade and promoting immune surveillance.^[30]^[31] Prostaglandins, synthesized de novo from arachidonic acid by activated mast cells and other inflammatory cells, further amplify this response by sensitizing nociceptors and sustaining vasodilation, particularly in postcapillary venules, to support prolonged leukocyte adhesion and migration.^[32] In systemic inflammatory conditions like sepsis, cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1) drive widespread endothelial activation, leading to profound vasodilation that contributes to distributive shock. This cytokine storm impairs vascular tone, resulting in hypotension and reduced organ perfusion, as the dilated vasculature fails to maintain systemic resistance despite increased cardiac output. In severe cases, this manifests as refractory hypotension, where the distributive component of shock predominates, exacerbating tissue hypoxia and multi-organ dysfunction.^[33]^[34] During wound healing, sustained vasodilation in the developing granulation tissue supports the proliferative phase by enhancing nutrient and oxygen delivery to proliferating fibroblasts and endothelial cells. This localized hyperemia, driven by ongoing release of vasodilatory mediators like nitric oxide and vascular endothelial growth factor (VEGF), promotes angiogenesis, where new capillary networks form to vascularize the provisional matrix, ensuring adequate oxygenation for collagen synthesis and epithelial migration. Without this vasodilatory environment, granulation tissue formation is compromised, delaying reepithelialization and increasing scar tissue.^[35]^[36] Intravital microscopy studies have quantified these changes, revealing a 2- to 3-fold increase in microvascular diameter in inflamed tissues, which correlates with elevated blood flow and enhanced leukocyte trafficking. For instance, in models of oxazolone-induced inflammation, quantitative imaging showed a 2.2-fold expansion in superficial vessel diameters, underscoring the magnitude of dilation in facilitating immune responses.^[37]

Mechanisms of Vasodilation

Vascular Smooth Muscle Physiology

Vascular smooth muscle cells (VSMCs) form the primary structural component of the tunica media in arterial and venous walls, where they are arranged in a circumferential orientation to regulate vessel diameter through contraction and relaxation.^[38] These cells are interconnected by gap junctions, primarily composed of connexin proteins such as Cx37, Cx40, and Cx43, which enable electrical and chemical coupling for synchronized propagation of signals across the vascular wall.^[39] This connectivity ensures coordinated vasomotor responses, allowing the media layer to function as a functional syncytium during physiological adjustments in blood flow.^[40] The electrophysiology of VSMCs is characterized by a resting membrane potential typically ranging from -40 to -60 mV, maintained by a balance of ion conductances, particularly potassium efflux through inward rectifier and leak K+ channels.^[41] In certain vascular beds, such as resistance arteries, spontaneous depolarization can trigger action potentials, which are often slow waves or spikes lasting tens to hundreds of milliseconds, leading to phasic contractions that rhythmically alter vessel tone.^[42] These action potentials facilitate Ca^{2+} entry via voltage-gated channels, promoting transient force generation, while dilation signals counteract this by promoting hyperpolarization to suppress excitability.^[43] Vasodilation in VSMCs primarily involves relaxation through membrane hyperpolarization, which is initiated by the opening of potassium channels, such as large-conductance Ca^{2+}-activated K+ (BK) or ATP-sensitive K+ (K_{ATP}) channels, leading to K+ efflux and a more negative membrane potential.^[44] This hyperpolarization reduces the opening probability of voltage-gated Ca^{2+} channels (VGCCs), thereby decreasing Ca^{2+} influx into the cytosol.^[45] Lower intracellular Ca^{2+} concentration ([Ca^{2+}]i) diminishes the activation of Ca^{2+}/calmodulin-dependent myosin light chain kinase (MLCK), reducing phosphorylation of the regulatory myosin light chain (MLC{20}) at serine 19.^[46] Consequently, dephosphorylated myosin heads exhibit lower affinity for actin, inhibiting cross-bridge cycling and actin-myosin interactions that generate contractile force.^[47] Force generation in VSMCs arises from actin-myosin interactions, where the relationship between contractile force and [Ca^{2+}]_i follows a sigmoidal curve described by the Hill equation for cooperative binding:

F = F_{\max} \frac{[\ce{Ca^{2+}}]_i^n}{K^n + [\ce{Ca^{2+}}]_i^n}

Here, F is the force, F_{\max} is the maximum force, K is the [Ca^{2+}]i at half-maximal force (pCa{50} ≈ 6.0–6.5 in VSMCs), and n is the Hill coefficient (typically 2–4, reflecting Ca^{2+} sensitivity).^[48] For conceptual simplicity in vasodilation contexts, this is often approximated as tension proportional to [Ca^{2+}]_i, emphasizing how reductions in [Ca^{2+}]_i directly attenuate force output.^[49] Endothelial cells can modulate VSMC relaxation by influencing these intrinsic mechanisms through diffusible factors, though the core machinery resides within the smooth muscle itself.^[50]

Endothelial-Derived Factors

The endothelium plays a central role in vasodilation by producing and releasing key signaling molecules known as endothelial-derived relaxing factors (EDRFs), which act on underlying vascular smooth muscle cells (VSMCs) to promote relaxation and vessel dilation.^[51] These factors are particularly responsive to stimuli such as shear stress from blood flow and various agonists, ensuring precise regulation of vascular tone.^[52] Among them, nitric oxide (NO) stands out as the primary EDRF, first identified in the 1980s through seminal studies demonstrating its role in endothelium-dependent relaxation.^[53] NO is synthesized by endothelial nitric oxide synthase (eNOS), an enzyme that catalyzes the conversion of L-arginine and molecular oxygen into NO and L-citrulline in the presence of cofactors like tetrahydrobiopterin (BH4).^[54] The synthesis pathway for NO is tightly regulated, with shear stress serving as a major physiological activator that enhances eNOS expression and activity through mechanotransduction mechanisms involving phosphorylation and calcium influx.^[55] Once produced, NO diffuses rapidly from the endothelium to adjacent VSMCs, where it binds to and activates soluble guanylate cyclase, leading to increased cyclic guanosine monophosphate (cGMP) levels.^[56] This, in turn, stimulates protein kinase G (PKG), which phosphorylates targets that reduce intracellular calcium and promote myosin light chain phosphatase activity, ultimately causing VSMC relaxation and vasodilation.^[52] In addition to NO, prostacyclin (PGI2), a prostanoid derived from arachidonic acid via cyclooxygenase-2 (COX-2) in endothelial cells, contributes to vasodilation by binding to IP receptors on VSMCs, thereby elevating cyclic adenosine monophosphate (cAMP) through adenylate cyclase activation.^[57] This cAMP increase inhibits calcium influx and promotes dephosphorylation of myosin light chains, facilitating smooth muscle relaxation.^[58] PGI2 production is stimulated by endothelial shear stress and inflammatory signals, complementing NO in maintaining vascular homeostasis.^[59] Another important endothelial-derived factor is the endothelium-derived hyperpolarizing factor (EDHF), which mediates vasodilation independently of NO and PGI2, particularly in smaller resistance vessels.^[60] EDHF promotes hyperpolarization of VSMCs by stimulating potassium efflux through endothelial potassium channels, such as small- and intermediate-conductance calcium-activated K+ channels (SKCa and IKCa), which spreads via myoendothelial gap junctions or direct diffusion of potassium ions.^[61] This hyperpolarization closes voltage-gated calcium channels, reducing calcium entry and inducing relaxation.^[62] EDHF's identity remains somewhat elusive but is often associated with epoxyeicosatrienoic acids or hydrogen peroxide in specific contexts.^[60] Dysregulation of these endothelial-derived factors underlies endothelial dysfunction, a hallmark of cardiovascular diseases, where reduced NO bioavailability impairs vasodilation.^[63] In atherosclerosis, oxidative stress from reactive oxygen species (ROS), such as superoxide, consumes NO to form peroxynitrite, diminishing its signaling efficacy and promoting vasoconstriction and plaque formation.^[64] This reduction in NO production or stability, often due to eNOS uncoupling from BH4 deficiency, exacerbates vascular inflammation and stiffness.^[65] Similar impairments in PGI2 and EDHF pathways contribute to diminished vasodilatory capacity in diseased states.^[61]

Causes and Triggers

Endogenous Chemical Mediators

Endogenous chemical mediators are intrinsic biochemical substances produced within the body that directly or indirectly induce vasodilation by acting on vascular smooth muscle or endothelial cells. These mediators include vasoactive peptides and metabolic byproducts, which play crucial roles in local and systemic regulation of blood flow in response to physiological demands such as tissue perfusion needs or inflammatory signals.^[66] Vasoactive peptides such as atrial natriuretic peptide (ANP) and bradykinin are key endogenous promoters of vasodilation. ANP, secreted by atrial myocytes in response to cardiac stretch, binds to natriuretic peptide receptor A (NPR-A), a transmembrane receptor with guanylyl cyclase activity that elevates intracellular cyclic guanosine monophosphate (cGMP) levels, leading to relaxation of vascular smooth muscle and potent dilation particularly in renal and systemic vessels.^[67]^[68] Similarly, bradykinin, generated locally from kininogen precursors during inflammation or tissue injury, binds primarily to B2 receptors on endothelial cells, which are Gq-coupled GPCRs that activate phospholipase C, increasing intracellular calcium to stimulate endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) production; NO then diffuses to smooth muscle cells, elevating cGMP and causing hyperpolarization and dilation in systemic and renal vasculature.^[69]^[70] In humans, bradykinin infusion into the forearm can double or more than triple blood flow by enhancing resistance vessel dilation.^[71] ANP administration reduces blood pressure by 10-15 mmHg through a combination of direct vasodilation and natriuresis-mediated volume reduction.^[72] Metabolic byproducts also contribute significantly to vasodilation, especially in hypoxic or metabolically active tissues. Adenosine, derived from the breakdown of adenosine triphosphate (ATP) during increased energy demand, acts primarily on A2A and A2B adenosine receptors, which are Gs-coupled GPCRs that stimulate adenylate cyclase to raise cAMP levels, thereby promoting vascular smooth muscle relaxation and coronary or skeletal muscle vasodilation.^[73]^[74] In hypoxic conditions, accumulation of lactate and hydrogen ions (H+) from anaerobic glycolysis further enhances vasodilation; lactate induces pH-independent relaxation of arterial smooth muscle, while acidosis from H+ directly inhibits voltage-gated calcium channels, reducing contraction in affected tissues.^[75]^[76] These mediators are tightly regulated by local cues, with production triggered by mechanical stretch for ANP or inflammatory processes for bradykinin, ensuring rapid and targeted responses.^[68]^[77] Their short half-lives—ranging from seconds for bradykinin (15-30 seconds) and adenosine (about 10 seconds) to minutes for ANP (2-4 minutes)—facilitate transient effects that match physiological needs without prolonged disruption.^[78] Endothelial nitric oxide often acts as a co-mediator in these pathways, amplifying the dilatory response.^[69]

Neural and Hormonal Control

The autonomic nervous system regulates vasodilation through both sympathetic and parasympathetic branches, with the sympathetic system typically promoting vasoconstriction via α-adrenergic receptors but paradoxically inducing dilation in specific vascular beds through alternative mechanisms. In certain tissues, such as the salivary glands, sympathetic cholinergic fibers release acetylcholine, which activates muscarinic receptors to cause vasodilation, enhancing glandular blood flow during stress responses like the "fight-or-flight" reaction.^[79] Additionally, β-adrenergic receptors, particularly β2 subtypes on vascular smooth muscle, mediate vasodilation by stimulating adenylyl cyclase to increase cyclic AMP (cAMP) levels, leading to relaxation and increased blood flow in skeletal muscle and coronary vessels during sympathetic activation.^[80] Parasympathetic control directly promotes vasodilation primarily through postganglionic fibers releasing acetylcholine, which binds to endothelial M3 muscarinic receptors, triggering the release of nitric oxide and subsequent smooth muscle relaxation. This mechanism is particularly prominent in cerebral vessels, where parasympathetic stimulation contributes to local blood flow adjustments, and in genital vasculature, facilitating erectile function by increasing penile blood flow.^[81] Nerves in this system release chemical mediators such as acetylcholine that act locally to amplify these effects.^[82] Hormonal regulation of vasodilation involves endocrine signals that modulate vascular tone over longer periods. Estrogen induces chronic vasodilation by upregulating endothelial nitric oxide synthase expression and activity, enhancing nitric oxide production and thereby reducing vascular resistance, an effect observed in premenopausal women and linked to cardiovascular protection.^[83] Insulin similarly promotes vasodilation in skeletal muscle vasculature by activating endothelial nitric oxide pathways, which increases capillary recruitment and blood flow to facilitate glucose uptake during postprandial states.^[84] Integrative reflexes, such as the baroreflex, coordinate neural and hormonal inputs to elicit widespread vasodilation in response to elevated blood pressure. Activation of baroreceptors in the carotid sinus during hypertension inhibits sympathetic outflow and enhances parasympathetic activity, resulting in systemic vasodilation and a reduction in mean arterial pressure by approximately 20-30%, as demonstrated in studies of carotid sinus nerve stimulation.^[85] This reflex helps maintain hemodynamic stability by counteracting hypertensive states through balanced autonomic control.^[86]

Environmental and Pathological Triggers

Environmental factors play a significant role in triggering vasodilation to maintain homeostasis. Exposure to heat stress induces cutaneous vasodilation primarily to facilitate heat dissipation through increased skin blood flow. Approximately 80–95% of this response during passive heat stress is mediated by active vasodilation mechanisms that enhance convective heat loss.^[87] In high-altitude environments, hypoxia triggers systemic vasodilation to improve oxygen delivery to tissues, contrasting with the pulmonary vasoconstriction that occurs concurrently. This systemic response involves hypoxia-inducible factor 1-alpha (HIF-1α) pathways that adapt vascular tone to low oxygen conditions.^[88] Cold exposure itself typically causes vasoconstriction to conserve heat, but upon rewarming, reactive hyperemia ensues due to the accumulation of vasodilatory metabolites like adenosine and nitric oxide in the ischemic tissues. This post-cold dilation restores blood flow and nutrient delivery to the extremities.^[89] Pathological conditions can provoke profound and often dysregulated vasodilation, leading to hemodynamic instability. In anaphylaxis, massive release of histamine from mast cells and basophils causes widespread vasodilation and increased vascular permeability, resulting in distributive shock characterized by hypotension and tissue hypoperfusion.^[90] Alcohol consumption induces transient facial flushing through vasodilation, primarily driven by acetaldehyde accumulation in individuals with aldehyde dehydrogenase 2 (ALDH2) deficiency, which heightens sensitivity in certain populations.^[91] Similarly, ingestion of spicy foods containing capsaicin activates transient receptor potential vanilloid 1 (TRPV1) channels on sensory nerves and vascular cells, eliciting cutaneous vasodilation and flushing as a neurogenic response.^[92] Emerging research highlights persistent vascular dysregulation in post-acute sequelae of SARS-CoV-2 infection (long COVID). Viral-induced endothelial damage leads to chronic endothelial dysfunction, manifesting as impaired vasodilation and increased vascular permeability, which contributes to symptoms like fatigue and orthostatic intolerance in affected individuals. This dysfunction is evidenced by reduced flow-mediated dilation in conduit arteries and correlates with ongoing inflammation.^[93]

Pharmacological Induction

Direct-Acting Vasodilators

Direct-acting vasodilators are a class of pharmacological agents that induce vasodilation by directly interacting with vascular smooth muscle cells, bypassing intermediary receptor activation to promote relaxation and reduce vascular tone. These drugs primarily target ion channels or intracellular signaling pathways within the smooth muscle, leading to decreased intracellular calcium levels or membrane hyperpolarization, which inhibits contraction. Common classes include calcium channel blockers, nitrovasodilators, and potassium channel openers, each exerting effects through distinct molecular mechanisms.^[94] Calcium channel blockers, such as nifedipine, represent a major subclass of direct-acting vasodilators that selectively inhibit the influx of calcium ions into vascular smooth muscle cells by binding to L-type voltage-gated calcium channels. This blockade prevents calcium-dependent activation of contractile proteins, resulting in relaxation of arterial smooth muscle and a reduction in systemic vascular resistance. Nifedipine, a dihydropyridine derivative, exhibits high vascular selectivity, primarily affecting peripheral arterioles without significant impact on cardiac conduction at therapeutic doses.^[95]^[96]^[97] Nitrovasodilators, including nitroglycerin and sodium nitroprusside, function by spontaneously releasing nitric oxide (NO) or NO-related species, which diffuse into vascular smooth muscle cells to activate soluble guanylate cyclase, elevating cyclic guanosine monophosphate (cGMP) levels and promoting dephosphorylation of myosin light chains for relaxation. This mechanism parallels the action of endogenous NO derived from endothelial cells, but nitrovasodilators act independently of nitric oxide synthase. Nitroglycerin is commonly administered sublingually or intravenously for acute vasodilation in conditions like angina, though prolonged use can lead to tolerance through oxidative inactivation and desensitization of aldehyde dehydrogenase-2 (ALDH2), the enzyme responsible for its bioactivation to NO. Sodium nitroprusside, another nitrovasodilator, is used intravenously in hypertensive emergencies with an initial infusion rate of 0.3 to 0.5 mcg/kg/min, titrated upward in increments to a maximum of 10 mcg/kg/min based on blood pressure response, requiring careful monitoring to avoid cyanide toxicity from its metabolism.^[98]^[99]^[100] Potassium channel openers, exemplified by minoxidil, directly activate ATP-sensitive potassium (K<sub>ATP</sub>) channels on the membrane of vascular smooth muscle cells, allowing potassium efflux that hyperpolarizes the cell membrane and closes voltage-gated calcium channels, thereby reducing calcium entry and inducing profound vasodilation. This action predominantly affects resistance arterioles, leading to decreased peripheral resistance, but can also cause reflex tachycardia due to baroreceptor activation. A notable side effect of minoxidil is hypertrichosis, attributed to its K<sub>ATP</sub> channel opening in hair follicle cells, which prolongs the anagen phase of hair growth.^[101]^[102]^[103]

Indirect Vasodilators via Receptor Modulation

Indirect vasodilators via receptor modulation exert their effects by targeting specific receptors or enzymes that influence secondary signaling pathways, such as cyclic nucleotides or peptide degradation, rather than directly acting on vascular smooth muscle ion channels or nitric oxide pathways. These agents primarily counteract vasoconstrictive signals or amplify relaxant mediators, leading to reduced vascular tone and blood pressure lowering. Examples include inhibitors of the renin-angiotensin-aldosterone system, adrenergic receptor modulators, and phosphodiesterase inhibitors, which are widely used in cardiovascular therapeutics.^[94] Angiotensin-converting enzyme (ACE) inhibitors, such as lisinopril, induce vasodilation by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor that acts via AT1 receptors to promote vascular smooth muscle contraction. This inhibition reduces angiotensin II-mediated constriction and simultaneously increases bradykinin levels, as ACE also degrades this vasodilatory peptide, enhancing endothelial-dependent relaxation.^[104]^[105] In clinical use, lisinopril exemplifies this class, with its effects contributing to improved endothelial function beyond mere pressure reduction.^[106] Angiotensin receptor blockers (ARBs), like losartan, achieve vasodilation by selectively antagonizing angiotensin II at AT1 receptors on vascular smooth muscle, preventing its constrictive effects without affecting AT2 receptors, which may promote dilation. This blockade leads to reduced aldosterone secretion and sympathetic activity, further supporting vasodilation and blood pressure control. ARBs also enhance endothelial nitric oxide production, amplifying their relaxant properties in hypertensive states.^[107]^[108] Alpha-2 adrenergic agonists, such as clonidine, promote vasodilation primarily through central mechanisms that reduce sympathetic outflow from the brainstem, decreasing norepinephrine release and alpha-1 mediated vasoconstriction in peripheral vessels. Peripherally, activation of presynaptic alpha-2A receptors inhibits neurotransmitter release, while postsynaptic effects can involve nitric oxide and prostaglandin pathways for direct relaxation in certain vascular beds, like coronary arteries. Clonidine's dual action results in dose-dependent hypotension, though rebound hypertension may occur upon withdrawal due to sudden sympathetic surge.^[109]^[110]^[111] Beta-2 adrenergic agonists, exemplified by salbutamol, stimulate beta-2 receptors on vascular smooth muscle, activating adenylate cyclase to elevate intracellular cyclic AMP (cAMP) levels, which inhibits calcium influx and promotes relaxation. This cAMP-mediated pathway is particularly effective in pulmonary and skeletal muscle vasculature, where beta-2 receptor density is high, leading to selective dilation with minimal cardiac stimulation due to beta-1 receptor sparing. Salbutamol's rapid onset makes it useful in acute settings for bronchodilation and associated vasodilation, with tachycardia being less prominent than with non-selective agents.^[112]^[113] Phosphodiesterase-5 (PDE5) inhibitors, such as sildenafil, enhance vasodilation by blocking the degradation of cyclic guanosine monophosphate (cGMP), a second messenger produced in response to nitric oxide that relaxes smooth muscle via protein kinase G activation and reduced calcium sensitivity. By inhibiting PDE5, these agents prolong cGMP's effects, particularly in pulmonary and penile vasculature, improving blood flow in conditions like pulmonary arterial hypertension (PAH). Sildenafil has an oral bioavailability of about 40% and a plasma half-life of approximately 4 hours, allowing thrice-daily dosing for PAH management, where it is FDA-approved at doses up to 20 mg three times daily.^[114]^[115]^[116]

Clinical and Therapeutic Aspects

Pathophysiological Implications

Excessive vasodilation plays a critical role in hypotensive states such as septic shock, where it contributes to profound hypotension and organ hypoperfusion. In septic shock, a cytokine storm triggered by the systemic inflammatory response leads to widespread endothelial activation and nitric oxide overproduction, resulting in maladaptive vasodilation that exacerbates circulatory failure. This condition is associated with high mortality rates exceeding 40% in hospitalized patients, highlighting the severe pathophysiological burden of dysregulated vasodilation in acute inflammatory contexts.^[117]^[118] Neurogenic vasodilation is implicated in migraine pathogenesis through the release of calcitonin gene-related peptide (CGRP) from trigeminal nerve endings, which induces meningeal vessel dilation and activates pain-sensing neurons, culminating in vascular headache. In rosacea, persistent facial vasodilation arises from chronic inflammatory stimuli that enhance cutaneous blood flow and endothelial dysfunction, leading to sustained erythema and telangiectasia in the central face. These mechanisms underscore how aberrant neurovascular signaling can perpetuate debilitating symptoms in primary headache and dermatological disorders.^[119]^[120] In chronic conditions like diabetes, impaired vasodilation due to endothelial dysfunction reduces nitric oxide bioavailability, promoting microvascular damage that contributes to diabetic neuropathy through ischemia and oxidative stress in peripheral nerves. Similarly, in heart failure, initial compensatory vasodilation mediated by vasodilatory factors such as nitric oxide and natriuretic peptides attempts to maintain cardiac output but becomes maladaptive, leading to neurohormonal imbalance, fluid retention, and progressive cardiac remodeling. These examples illustrate the transition from adaptive to pathological vascular responses in metabolic and cardiovascular diseases.^[121]^[122]^[123] Recent studies from 2023 have linked microvascular dilation defects in long COVID to persistent fatigue, with endothelial dysfunction and impaired vasoreactivity observed in affected patients, contributing to symptoms as seen in cohorts with overall long COVID prevalence of 10-35%. These findings suggest that lingering vascular impairments post-infection may underlie chronic fatigue syndromes, emphasizing the evolving recognition of vasodilation dysregulation in post-viral pathologies.^[124]

Therapeutic Applications and Treatments

Vasodilators play a central role in hypertension management, particularly as first-line agents for moderate to severe cases where blood pressure control is challenging with other therapies alone. For instance, hydralazine is commonly combined with beta-blockers to effectively lower blood pressure while countering reflex tachycardia, a common side effect that can exacerbate cardiovascular strain. This combination has demonstrated additive antihypertensive effects, improving outcomes in patients with resistant hypertension without significantly impairing renal function.^[125]^[126] In ischemic conditions, vasodilation is therapeutically induced to enhance blood flow to oxygen-deprived tissues. For angina pectoris, organic nitrates such as nitroglycerin are a mainstay, providing rapid coronary artery dilation to relieve chest pain by reducing preload and afterload on the heart. This approach improves myocardial oxygen supply-demand balance and is recommended for both acute episodes and chronic stable angina management. In peripheral artery disease, cilostazol is specifically used to alleviate intermittent claudication symptoms, increasing pain-free walking distance by promoting vasodilation and inhibiting platelet aggregation, with meta-analyses confirming its efficacy over placebo in improving absolute claudication distances.^[127]^[128] Beyond cardiovascular applications, vasodilation-targeted therapies address other vascular disorders. Phosphodiesterase-5 (PDE5) inhibitors, such as sildenafil, are first-line treatments for erectile dysfunction, enhancing penile vasodilation by preserving cyclic guanosine monophosphate levels to facilitate smooth muscle relaxation and improved blood flow. For Raynaud's phenomenon, topical nitroglycerin ointment provides localized vasodilation, reducing digital ischemia episodes and promoting rewarming in affected extremities, with formulations like 2% ointment applied as needed to minimize systemic absorption.^[114]^[129] Recent advances in vasodilation therapies emphasize targeted interventions to improve efficacy and safety. In 2024-2025, the SAPPHIRE trial evaluated endothelial nitric oxide synthase (eNOS) gene-enhanced autologous endothelial progenitor cells delivered via intravenous infusions for progressive pulmonary arterial hypertension, showing possible clinical benefits, such as improved 6-minute walk distance, in patients on standard therapies. Combination regimens, such as vasodilators paired with beta-blockers or volume expanders, have also been refined to mitigate side effects like orthostatic hypotension, enhancing tolerability by stabilizing hemodynamic responses during posture changes.^[130]^[125]

References

[1]
Physiology, Vasodilation - StatPearls - NCBI Bookshelf
Jan 23, 2023 · Vasodilation is the widening of blood vessels due to the relaxation of the blood vessel's muscular walls. It is a mechanism to enhance blood flow to areas of ...
[2]
Physiology, Cardiovascular - StatPearls - NCBI Bookshelf - NIH
Oct 16, 2022 · The increase or decrease in metabolism leads to increased or decreased metabolic byproducts that cause vasodilation. Increased adenosine ...
[3]
Endothelium-Dependent Regulation of Vascular Tone - NCBI
Endothelial cells control the tone of the underlying vascular smooth muscle cells by releasing various relaxing and contracting factors.NITRIC OXIDE SYNTHASES · METABOLISM OF...
[4]
Physiology, Peripheral Vascular Resistance - StatPearls - NCBI - NIH
When blood vessels dilate (vasodilation), this leads to a decrease in SVR. If referring to resistance within the pulmonary vasculature, this is called pulmonary ...
[5]
The Endothelium and Its Role in Regulating Vascular Tone - PMC
Nitric oxide (NO) is an endothelium-dependent vasodilator of the underlying smooth muscle and was first identified by Furchgott and Zawadzki [14]. NO has been ...
[6]
Anatomy, Arterioles - StatPearls - NCBI Bookshelf - NIH
Venules serve as exit vessels in the capillary bed of various organs and unite to form veins, which return the blood to the heart. The arteriolar wall consists ...
[7]
Signaling Mechanisms Underlying the Vascular Myogenic Response
Historical Perspective. Discovery of the myogenic response is credited to Bayliss in 1902, when he recorded large increases in the volume of the dog hindlimb ...
[8]
The Circulatory System and Oxygen Transport - NCBI - NIH
Vasodilation ensues, lowering resistance to blood flow. The resulting increase in blood flow increases the oxygen supply, and finally, a new steady state is ...
[9]
Physiology, Systemic Vascular Resistance - StatPearls - NCBI - NIH
Jul 10, 2023 · Systemic vascular resistance (SVR), also known as total peripheral resistance (TPR), is the amount of force exerted on circulating blood by the vasculature of ...
[10]
Nitric oxide control of lower vertebrate blood vessels by vasomotor ...
The role of NO in the control of vascular tone in non-mammalian vertebrates has received less attention than mammals.<|separator|>
[11]
Hemoglobin, nitric oxide and molecular mechanisms of hypoxic ...
The hallmark of hypoxic vasodilation is local reduction in vascular resistance correlated with decreased oxygen saturation of Hb. This effect was reported in ...Matching Perfusion With... · Integrating What We Know · S-Nitrosothiol-Mediated...Missing: comparative | Show results with:comparative
[12]
Ultrasound Assessment of Endothelial Function - PubMed Central
Apr 27, 2016 · The FMD test is now the most widely utilized, non-invasive, ultrasonic assessment of endothelial function in humans and has been associated with future ...
[13]
Venous occlusion plethysmography in cardiovascular research - NIH
Blood flow can also be measured using ultrasound. Usually this involves combining estimates of mean blood velocity with the cross sectional area of the vessel.
[14]
Exercise and Vascular Insulin Sensitivity in Skeletal Muscle and Brain
During the transition from rest to maximal exercise, skeletal muscle blood flow may increase up to a 10-fold and can reach up to 300–400 mL∙100 g−1∙min−1 (47,55 ...<|control11|><|separator|>
[15]
Exercise Hyperemia and Regulation of Tissue Oxygenation During ...
Vasodilation of the arterial tree results in increased blood flow, which carries more oxygen to the tissues per unit time. In addition, the enhanced blood flow ...<|separator|>
[16]
Regulation of Increased Blood Flow (Hyperemia) to Muscles During ...
This review focuses on how blood flow to contracting skeletal muscles is regulated during exercise in humans.
[17]
Coronary nitric oxide production in response to exercise ... - PubMed
Coronary NO production in response to endothelium-dependent agonists is greater than in response to the increase in shear stress associated with exercise.
[18]
Cerebral Blood Flow Autoregulation and Dysautoregulation - PMC
In healthy adults, the limits are between 50 and 150 mm Hg cerebral perfusion pressure (CPP) or 60 and 160 mm Hg mean arterial pressure (MAP), where CPP = MAP – ...
[19]
Baroreceptor modulation of the cardiovascular system, pain ...
Both arterial and cardiopulmonary baroreceptors inhibit sympathetically mediated vasoconstriction, causing vasodilatation; yet, only arterial baroreceptors ...
[20]
Peripheral mechanisms of thermoregulatory control of skin blood ...
Human skin blood flow is controlled via dual innervation from the sympathetic nervous system. Reflex cutaneous vasoconstriction and vasodilation are both ...
[21]
Mechanisms and modifiers of reflex induced cutaneous vasodilation ...
Decreases in mean skin and/or internal temperatures cause reflex activation of sympathetic vasoconstrictor nerves, resulting in cutaneous vasoconstriction and ...
[22]
Physiology, Temperature Regulation - StatPearls - NCBI Bookshelf
Jul 30, 2023 · Activating sympathetic cholinergic fibers innervating sweat glands, leading to increased sweat and increased heat loss. Inhibiting sympathetic ...
[23]
Central nervous system circuits that control body temperature - PMC
Dec 23, 2018 · The sympathetic fibers responsible for cutaneous active vasodilation are cholinergic, as opposed to the noradrenergic cutaneous ...
[24]
Control of internal temperature threshold for active cutaneous ...
Exercise induces shifts in the internal temperature threshold at which cutaneous vasodilation begins. To find whether this shift is accomplished through the ...Missing: core | Show results with:core
[25]
interrogation and understanding of the control of skin blood flow - PMC
Nov 27, 2019 · ... 5% of cardiac output. Skin arterioles are richly innervated by ... skin blood flow in humans. Microvasc Res. 2011;82(2):147–151. doi ...
[26]
[PDF] PREVENTION AND TREATMENT OF HEAT AND COLD STRESS ...
During heat stress, skin blood flow can be 60% of cardiac output. [PMID 8504843].15 In heat stress conditions, blood flow to the skin must be maintained so ...
[27]
Cardiovascular function in the heat-stressed human - PMC
During pronounced passive heat stress, skin blood flow of humans is estimated to increase from ~300 mL min−1 upwards to 7500 mL min−1 (Rowell et al. 1969a, ...
[28]
Impairment of microcirculation and vascular responsiveness in ... - NIH
Mar 23, 2018 · Impaired transient vasodilation and increased vasoconstriction to digital local cooling in primary Raynaud's phenomenon. AJP Heart Circ ...
[29]
Raynaud's Phenomenon: A Brief Review of the Underlying ... - NIH
Nov 16, 2016 · Raynaud's phenomenon (RP) is characterized by exaggerated cold-induced vasoconstriction. This augmented vasoconstriction occurs by virtue of a reflex response ...
[30]
Mast cells and inflammation - PMC - PubMed Central - NIH
Once activated, mast cells secrete numerous vasoactive and pro-inflammatory mediators [37-42]. These include pre-formed molecules such as histamine, serotonin, ...
[31]
Histamine Induces Vascular Hyperpermeability by Increasing Blood ...
Jul 9, 2015 · During allergic inflammation, activated mast cells release a large amount of histamine, leading to vascular hyperpermeability [15, 16]. Since ...
[32]
Prostaglandins and Inflammation - PMC - PubMed Central - NIH
Prostaglandins play a key role in the generation of the inflammatory response. Their biosynthesis is significantly increased in inflamed tissue.Prostaglandins And... · Prostaglandin Receptors · Prostaglandin E And...Missing: histamine | Show results with:histamine
[33]
Distributive Shock - StatPearls - NCBI Bookshelf - NIH
Inflammatory cytokines released in both sepsis and toxic shock syndrome induce systemic vasodilation and capillary leak, as well as cardiomyopathy. The systemic ...
[34]
Cytokines in Sepsis: Potent Immunoregulators and Potential ...
However, a dysregulated cytokine release may lead to endothelial dysfunction, characterized by vasodilation and increased capillary permeability.
[35]
The Skin Blood Flow Response in Wound Healing - ScienceDirect
Although vasodilation is conventionally held to be the predominant microvascular response to a wound, there has been no previous attempt to actually ...
[36]
Therapeutic Strategies for Enhancing Angiogenesis in Wound Healing
This review surveys the creation of new treatments for healing cutaneous wounds through therapeutic angiogenesis.
[37]
Spatial variation of plasma flow in the oxazolone-stimulated ...
Quantitative morphometry of intravital microscopic images demonstrated a 2.2-fold increase in the mean diameter of vessels in the superficial vascular plexus (p ...
[38]
Vascular Smooth Muscle Structure and Function - NCBI - NIH
As with other muscle types smooth muscle functions best when at its optimal resting length L0, which provides the ideal balance of actin-myosin interaction and ...
[39]
Role of smooth muscle cells in Cardiovascular Disease - PMC
... smooth muscle cells (SMCs) are localized in the tunica media ... gap junctions exist between cells to realize the electric and chemical coupling between cells.
[40]
BIOLOGICAL AND BIOPHYSICAL PROPERTIES OF VASCULAR ...
Gap junctions can be morphologically identified within the vasculature at sites of endothelial cell (EC), vascular smooth muscle cell (VSMC), and EC and VSMC ...2 The Vasculature · 3 Connexin Channels · 4 Gap Junctional...
[41]
Contribution of Ca2+-activated K+ channels and non-selective ... - NIH
Resting membrane potentials of arterial smooth muscle cells were reported to be in the range between -40 to approximately -60 mV, varying according to the ...
[42]
Electrical and Mechanical Characteristics of Vascular Smooth ...
This vascular smooth muscle shows spontaneous phasic contractions correlated with bursts of action potentials. Norepinephrine (10-99 to 10-7 w/v) increases ...
[43]
SMOOTH MUSCLE CONTRACTION AND RELAXATION
In most smooth muscles, PKC has contraction-promoting effects such as phosphorylation of Ca2+ channels or other proteins that regulate cross-bridge cycling.Missing: K+ Ca2+
[44]
Potassium Channels in Regulation of Vascular Smooth Muscle ... - NIH
KCa channel antagonists reduce NO donor-mediated relaxation of vascular and tracheal smooth muscle. ... K+ channel openers inhibits Ca2+ influx and Ca2+ release ...
[45]
Calcium-Activated Potassium Channels and the Regulation of ...
Feb 1, 2006 · The critical influence of Ca2+-activated K+ channels in both endothelium and smooth muscle cells suggests an involvement in cardiovascular ...
[46]
Interactions Between Ca2+ and H+ and Functional Consequences ...
Relaxation occurs when [Ca2+]i falls and the myosin light chains are dephosphorylated. Receptor-mediated stimulation of vascular smooth muscle may also alter ...
[47]
Evolving Mechanisms of Vascular Smooth Muscle Contraction ...
The agonist also stimulates Ca2+ influx through Ca2+ channels. Ca2+ binds calmodulin (CaM), activates MLC kinase (MLCK), causes MLC phosphorylation, and ...
[48]
Regulation of force in skinned, single cells of ferret aortic smooth ...
Plots of relative steady-state force vs pCa (−log10[Ca2+]) were fit to the Hill equation, which yielded a pCa at half-maximal force of 6.87 ± 0.30 and a Hill ...
[49]
Hill's equation of muscle performance and its hidden insight on ...
Nov 25, 2013 · In this Review, an analysis is presented to illustrate the connection between the historic Hill equation and the kinetics of myosin cross-bridge ...Missing: vascular | Show results with:vascular
[50]
Mechanisms of Vascular Smooth Muscle Contraction and the Basis ...
In many VSMC, tissues sparks are targeted to large conductance Ca2+-dependent K+ channels (BK) that oppose vasoconstriction by allowing hyperpolarizing outward ...
[51]
Physiology, Endothelial Derived Relaxation Factor - StatPearls - NCBI
May 1, 2023 · Endothelium-derived relaxing factor (EDRF) is an endogenous vasodilator that endothelial cells produce and subsequently release in response to various changes ...Introduction · Function · Pathophysiology · Clinical SignificanceMissing: seminal papers
[52]
The Identification of Nitric Oxide as Endothelium-Derived Relaxing ...
Jul 5, 2013 · The identification of endothelium-derived relaxing factor as nitric oxide (NO) dramatically altered the course of vascular biology, ...
[53]
Nitric oxide release accounts for the biological activity of ... - Nature
Jun 11, 1987 · Endothelium-derived relaxing factor (EDRF) is a labile humoral agent which mediates the action of some vasodilators.Missing: seminal papers
[54]
Nitric oxide synthases: regulation and function - PMC
The best established such stimulus is fluid shear stress. This activation is mediated by phosphorylation of the enzyme.
[55]
Flow-dependent regulation of endothelial nitric oxide synthase
Though it is well known that shear stress stimulates NO production from endothelial nitric oxide synthase (eNOS), the underlying molecular mechanisms remain ...
[56]
Endothelium-derived relaxing factor produced and released ... - PNAS
The objective of this study was to determine whether nitric oxide (NO) is responsible for the vascular smooth muscle relaxation elicited by endothelium-derived ...Missing: papers | Show results with:papers
[57]
Physiology, Prostaglandin I2 - StatPearls - NCBI Bookshelf
Aug 28, 2023 · Organ Systems Involved. PGI2 acts to promote vasodilation in vascular endothelial cells and pulmonary vessels. Hematologically, it also ...
[58]
Biology and therapeutic potential of prostacyclin.
97'98 Nordoy and co-workers99 were the first to show that LDL reduced the release of a prostacyclin- like substance by human endothelial cells. Beitz and.
[59]
Prostacyclin - an overview | ScienceDirect Topics
Prostacyclin (PGI2) is released by vascular endothelial cells and serves as a potent vasodilator, inhibitor of platelet aggregation (anti-thrombotic), and ...
[60]
Endothelium-Derived Hyperpolarizing Factor and Vascular Function
Endothelium-derived hyperpolarizing factor (EDHF) is a non-NO, non-prostaglandin mediator of vasodilation, increasing potassium conductance to cause vascular ...
[61]
Endothelium-Derived Hyperpolarizing Factor | Arteriosclerosis ...
The purpose of this review is to highlight the different pathways that can lead to endothelium-dependent hyperpolarization of the vascular smooth muscle cells.
[62]
The endothelium-derived hyperpolarizing factor - ScienceDirect.com
Jul 2, 2007 · In this mini review, we wish to convey that EDHF is as powerful as NO and PGI2 in terms of blood pressure regulation and that deficiency in EDHF ...
[63]
Role of Endothelial Dysfunction in Atherosclerosis | Circulation
Oxidative stress can also interfere with the production and activity of NO by a number of mechanisms that are independent of LDL. For example, the free radical ...Regulatory Functions Of The... · Nitric Oxide · Correction Of Endothelial...
[64]
Oxidative stress and reactive oxygen species in endothelial ...
This ultimately leads to reduced nitric oxide (NO) bioavailability, impairment of the vascular tone and other endothelial phenotypic changes collectively termed ...
[65]
Endothelial dysfunction due to eNOS uncoupling
Mar 9, 2023 · eNOS uncoupling is often triggered by oxidative stress associated with cardiovascular risk factors, including diabetes, hypertension, ...
[66]
Fluid Therapy and the Microcirculation in Health and Critical Illness
Systemically acting vasodilators include the kinins, adrenomedullin and atrial natriuretic peptide (ANP). The kinins include bradykinin and l-lysyl-bradykinin ...Missing: H+ | Show results with:H+
[67]
Atrial Natriuretic Peptide - StatPearls - NCBI Bookshelf - NIH
ANP exerts its effects by increasing the amounts of cyclic guanosine monophosphate (cGMP) circulating in target tissues.[1] The impact on these target tissues ...Missing: GPCR | Show results with:GPCR
[68]
Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)
Sep 10, 2015 · Atrial natriuretic peptide (ANP) is a cardiac hormone that regulates salt-water balance and blood pressure by promoting renal sodium and water excretion.Missing: reduction | Show results with:reduction
[69]
Bradykinin-induced vasodilation of human forearm resistance ...
BK is a potent vasodilator peptide in human forearm resistance vessels, causing vasodilation through hyperpolarization of the vascular wall independent of NO ...
[70]
Function and structure of bradykinin receptor 2 for drug discovery
Sep 8, 2022 · Type 2 bradykinin receptor (B2R) is an essential G protein-coupled receptor (GPCR) that regulates the cardiovascular system as a vasodepressor.
[71]
Angiotensin-(1-7) does not affect vasodilator or TPA ... - PubMed - NIH
There were no systemic hemodynamic effects of the agonists. Bradykinin significantly increased forearm blood flow (P<0.001, from 3.8+/-0.5 to 13.9+/-3.1 mL/min ...
[72]
Cardiovascular, renal and endocrine effects of alpha-human atrial ...
There were significant decreases in the mean blood pressure (-10 to -15 mmHg) in patients with Cushing's syndrome and primary aldosteronism, similar to those in ...<|separator|>
[73]
Adenosine receptors and the heart: role in regulation of coronary ...
In general, A(2A)AR is the predominant receptor subtype responsible for coronary blood flow regulation, which dilates coronary arteries in both an endothelial- ...Missing: A2 | Show results with:A2
[74]
Adenosine activates ATP-sensitive potassium channels in arterial ...
Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase. T Kleppisch and M T Nelson ...
[75]
Lactate-induced vascular relaxation in porcine coronary arteries is ...
Although lactate causes pH-independent vasorelaxation, the mechanisms responsible for this effect are unclear. We investigated the effect of lactate on K+ ...
[76]
Current understanding of the contribution of lactate to the ... - Frontiers
Under ischemic or hypoxic conditions, a considerably increased lactate production results in vasodilation with a marked reduction in vascular resistance (8, 60) ...
[77]
A comprehensive review on current understanding of bradykinin in ...
May 21, 2022 · Bradykinin is a potent, transient vasoactive peptide that acts as a vasodilator and an inflammatory mediator in various signaling cascades.
[78]
Bradykinin Contributes to the Vasodilator Effects of Chronic ...
Bradykinin is a potent endothelium-dependent vasodilator that has a brief duration of action (plasma half-life of 15 to 30 sec) because of its rapid degradation ...Missing: ANP | Show results with:ANP
[79]
Nervous Control of Blood Flow in the Orofacial Region - ScienceDirect
At least four different vasomotor responses are considered to occur in the orofacial region: (1) sympathetic vasoconstriction, (2) sympathetic vasodilation, (3) ...<|separator|>
[80]
Role of α- and β-adrenergic signaling in phenotypic targeting
Jul 20, 2021 · Alpha (α) adrenoceptors mediate smooth muscle contraction and vasoconstriction, while beta (β) receptors mediate vasodilation, smooth muscle ...<|separator|>
[81]
Physiology, Muscarinic Receptor - StatPearls - NCBI Bookshelf - NIH
[1] The molecule acetylcholine activates muscarinic receptors, allowing for a parasympathetic reaction in any organs and tissues where the receptor is expressed ...Missing: genital | Show results with:genital
[82]
Neuroanatomy, Parasympathetic Nervous System - StatPearls - NCBI
In salivary glands, parasympathetic stimulation of M1 and M3 receptors leads to high-volume secretion of potassium ions, water, and amylase. In the stomach ...
[83]
Estrogen and vascular function - PubMed - NIH
Estrogen is also a vasodilator and hypotensive agent, and can induce vascular relaxation by stimulating release of endothelium-derived vasodilatory substances.
[84]
The vascular actions of insulin control its delivery to muscle and ...
Insulin can relax resistance vessels and increase blood flow to skeletal muscle. However, there is controversy as to whether this occurs at physiological ...
[85]
Blood Pressure Regulation by the Carotid Sinus Nerve - Frontiers
Jan 9, 2022 · Likewise, stimulation of CSN with 20 Hz frequency produced a decrease in blood pressure of 24.1% (MBP 20 Hz = 65.0 ± 11.92 mmHg) (Figure 3D).<|control11|><|separator|>
[86]
Baroreflex stimulation: A novel treatment option for resistant ...
Upon stimulation of the carotid sinuses, there was an immediate fall in mean arterial pressure (MAP) of ~ 25 mmHg in association with a modest reduction in ...Missing: drop | Show results with:drop
[87]
Effect of heat stress on vascular outcomes in humans - PMC
The hallmark physiological response to heat stress is the cutaneous vasodilation that allows for the necessary redirection of blood flow to the surface of the ...
[88]
HIF and pulmonary vascular responses to hypoxia - PMC
Moderate levels of hypoxia (4% oxygen) also induce HIF-1α protein, but through a different mechanism, requiring longer duration of hypoxic exposure and ...
[89]
Cold-water immersion and other forms of cryotherapy: physiological ...
Sep 1, 2013 · Cold may facilitate recovery from metabolically stressful exercise by reducing intramuscular temperature and metabolism [31] to ease hypoxic ...Missing: hyperemia | Show results with:hyperemia<|separator|>
[90]
Anaphylaxis - StatPearls - NCBI Bookshelf - NIH
Histamine increases vascular permeability and vasodilation ... Anaphylaxis induces a distributive shock that typically is responsive to fluid resuscitation and ...
[91]
The Alcohol Flushing Response: An Unrecognized Risk Factor ... - NIH
Mar 24, 2009 · Acetaldehyde is responsible for the facial flushing and other unpleasant effects that ALDH2-deficient individuals experience when they drink ...
[92]
Rosacea and Diet: What is New in 2021? - PMC - NIH
Regarding the mechanism of these triggers, TRPV1 receptor might be activated by capsaicin found in spicy foods, causing vasodilation and flushing.8,18–19.
[93]
Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome
Post-acute COVID-19 syndrome is associated with a persistent and sex-biased endothelial dysfunction, directly correlated with the severity of pulmonary ...Missing: haul | Show results with:haul
[94]
Vasodilators - StatPearls - NCBI Bookshelf - NIH
Aug 14, 2023 · This review will focus more on direct-acting vasodilators, calcium channel blockers, and renin-angiotensin-aldosterone antagonists as these ...Continuing Education Activity · Indications · Mechanism of Action · Administration
[95]
Calcium Channel Blockers - StatPearls - NCBI Bookshelf
Feb 22, 2024 · Mechanism of Action. CCBs block the inward movement of calcium by binding to the L-type “long-acting” voltage-gated calcium channels in the ...
[96]
Nifedipine - StatPearls - NCBI Bookshelf
Jul 6, 2025 · Nifedipine is a dihydropyridine calcium channel blocker approved for the treatment of chronic stable angina and hypertension.
[97]
Nifedipine and hypertension: roles of vasodilation and sodium balance
Nifedipine reduces blood pressure predominantly by reducing systemic vascular resistance due to a direct vasodilating action on the arterioles.
[98]
The enigma of nitroglycerin bioactivation and nitrate tolerance
By testing different organic nitrates, the authors found that at least three nitro groups must be present in the molecule to enable bioactivation by ALDH2.
[99]
Sodium Nitroprusside - StatPearls - NCBI Bookshelf
May 22, 2023 · Typical infusion rates range from 0.5 to 4 mcg/kg/minute which are then titrated to desired effect. Typical infusion concentrations for adults ...Continuing Education Activity · Indications · Administration · Contraindications
[100]
Formation of Nitric Oxide by Aldehyde Dehydrogenase-2 Is ... - NIH
Aldehyde dehydrogenase-2 (ALDH2) catalyzes vascular bioactivation of the antianginal drug nitroglycerin (GTN), resulting in activation of soluble guanylate ...
[101]
Minoxidil: An Underused Vasodilator for Resistant or Severe ...
In large measure, minoxidil acts by opening adenosine triphosphate‐sensitive potassium channels in vascular smooth muscle cells. The ensuing vasodilation is ...
[102]
Minoxidil-induced hair growth is mediated by adenosine in cultured ...
The mechanism by which minoxidil, an adenosine-triphosphate-sensitive potassium channel opener, induces hypertrichosis remains to be elucidated.
[103]
Applications and efficacy of minoxidil in dermatology - PMC - NIH
By opening potassium channels, minoxidil is thought to hyperpolarize cell membranes, leading to increased blood flow around hair follicles.
[104]
ACE Inhibitors - StatPearls - NCBI Bookshelf - NIH
May 4, 2025 · Bradykinin induces prominent vasodilation ... Hyperkalemia: Hyperkalemia from ACE inhibitors directly results from its mechanism of action.Indications · Mechanism of Action · Adverse Effects · Contraindications
[105]
Angiotensin-Converting Enzyme Inhibitors (ACEI) - StatPearls - NCBI
Also, the hypothesis is that ACE inhibitors interfere with the degradation of bradykinin, a peptide that causes vasodilation.[32]. Angiotensin-converting enzyme ...
[106]
Small molecule angiotensin converting enzyme inhibitors
Nov 1, 2022 · Angiotensin-converting-enzyme inhibitors (ACE inhibitors, ACEIs) decrease the formation of angiotensin II and increase the level of bradykinin, thus relaxing ...<|separator|>
[107]
Angiotensin II Receptor Blockers (ARB) - StatPearls - NCBI Bookshelf
May 5, 2025 · This inhibition leads to vasodilation, reduced aldosterone secretion, and decreased blood pressure.
[108]
Effects of angiotensin receptor blockers on endothelial nitric oxide ...
While ARBs improve vasodilation in patients with hypertension through suppression of angiotensin II, these agents may have additional effects on eNOS function.
[109]
Clonidine - StatPearls - NCBI Bookshelf
Mechanism of Action. Clonidine hydrochloride is an imidazoline derivative that acts centrally on alpha-2 adrenergic as an agonist. The chemical name for ...
[110]
and prostaglandin-mediated vasodilation in healthy human skin
Clonidine induces nitric oxide- and prostaglandin-mediated vasodilation in healthy human skin ... alpha(2)-receptor stimulation mediates this vasodilation. We ...
[111]
The mechanism for the clonidine-induced coronary artery dilatation ...
Clonidine when administered directly into the coronary vascular bed in doses of 30, 100, and 300 micrograms induced a dose dependent coronary vasodilation, ...
[112]
Isoproterenol - StatPearls - NCBI Bookshelf
Isoproterenol is a beta-1 and beta-2 adrenergic receptor agonist resulting in the following: Increased heart rate. Increased heart contractility. Relaxation of ...Continuing Education Activity · Indications · Mechanism of Action · Contraindications
[113]
Pulmonary vascular smooth muscle relaxation by cAMP-mediated ...
Relaxation by beta2-adrenergic receptor activation was most effective as complete ring relaxation was achieved at 10(-6) M isoproterenol with a median effective ...
[114]
PDE5 Inhibitors - StatPearls - NCBI Bookshelf - NIH
... cGMP, leading to vasodilation and increased penile blood flow. Mechanism of PDE-5 Inhibitors on cGMP. These drugs inhibit the enzyme phosphodiesterase-5 (PDE ...
[115]
Sildenafil - StatPearls - NCBI Bookshelf - NIH
... inhibitor of cGMP-specific PDE5. This enzyme normally catalyzes the breakdown of vasodilatory cGMP. When PDE5 is active, cGMP is degraded, causing the ...
[116]
Management Considerations for Pulmonary Arterial Hypertension ...
Sep 13, 2023 · Sildenafil has a half-life of 4 h and is dosed three times daily, whereas tadalafil has a half-life of 35 h and is dosed once daily [13,14].
[117]
Why Septic Patients Remain Sick After Hospital Discharge? - Frontiers
Feb 14, 2021 · Hospital mortality of patients with septic shock is more than 40% (2). Sepsis is widely recognized as a highly life-threatening condition ...
[118]
The effects of sepsis on endothelium and clinical implications - NIH
Sepsis accounts for nearly 700 000 deaths in Europe annually and is caused by an overwhelming host response to infection resulting in organ failure.
[119]
Calcitonin gene-related peptide (CGRP): Role in migraine ...
However, not all vasodilators can induce migraine headache. Specifically, vasoactive intestinal peptide (VIP) induces vasodilation but does not induce migraine, ...
[120]
Advances in Understanding and Managing Rosacea: Part 1
During disease flares, there is increased vasodilation, cutaneous blood flow, and fluid extravasation secondary to the inflammatory effects associated with the ...
[121]
Endothelial dysfunction in diabetes - PMC - NIH
Impaired endothelium-dependent vasodilation has been demonstrated in various vascular beds of different animal models of diabetes and in humans with type 1 and ...
[122]
Endothelial Dysfunction as a Link Between Cardiovascular Risk ...
This study shows that endothelial dysfunction occurs early in the pathophysiology of diabetes and is a link between cardiovascular risk factors and DPN.
[123]
Pathophysiology of heart failure - PMC - PubMed Central - NIH
There is an imbalance in human heart failure between vasoconstrictive and vasodilatory factors (nitric oxide, bradykinin, natriuretic peptides). Myocardial ...
[124]
Persistent endothelial dysfunction in post-COVID-19 syndrome and ...
Jul 28, 2023 · The association of microvascular changes with PCS severity were amplified in PCS patients exhibiting higher levels of inflammatory parameters.Missing: defects | Show results with:defects
[125]
Combined Therapy with Vasodilator Drugs and Beta-Adrenergic ...
The hypotensive efficacies of two vasodilators, hydralazine and minoxidil, were assessed as these drugs were used individually in combination with beta- ...
[126]
Hydrallazine with beta-blocker and diuretic in the ... - PubMed
The combination was effective in patients with renal hypertension and renal impairment. No adverse effects on renal function were observed.
[127]
Vasodilators & the Treatment of Angina Pectoris - AccessMedicine
The organic nitrates, eg, nitroglycerin, are the mainstay of therapy for the immediate relief of angina. Another group of vasodilators, the calcium channel ...
[128]
Cilostazol for intermittent claudication - PubMed
Jun 30, 2021 · Cilostazol has been shown to improve walking distance in people with intermittent claudication. However, participants taking cilostazol had ...
[129]
Use of nitroglycerin ointment to treat primary and ... - PubMed
Topical nitrates are well suited for as-needed use, and several different formulations have been studied for the treatment of RP, including ointments, gels, ...
[130]
Study of angiogenic cell therapy for progressive pulmonary arterial ...
May 27, 2025 · The SAPPHIRE trial was designed to assess the efficacy of four monthly IV infusions of eNOS gene-enhanced autologous EPCs in patients with PAH ...